Literature DB >> 1925287

Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review.

M Green1, E R Wald, A Tzakis, S Todo, T E Starzl.   

Abstract

A 2-month-old infant who had undergone orthotopic liver transplantation at the age of 2 weeks for carbamoyl phosphate synthetase deficiency developed infection of the CNS due to Aspergillus fumigatus. The patient was successfully treated with administration of a combination of antifungal agents (including intraventricular amphotericin B), drainage of the parietal lobe abscess, and cessation of immunosuppression. An intraventricular catheter was used both to obtain ventricular fluid for microbiologic testing and to deliver amphotericin B during nearly 4 months of treatment. We review literature on aspergillosis in solid-organ transplant recipients, especially those in whom the disease involves the CNS, and discuss in particular clinical presentation, diagnosis, treatment, and outcome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1925287      PMCID: PMC2955443          DOI: 10.1093/clinids/13.4.653

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  41 in total

Review 1.  Susceptibility of Candida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies.

Authors:  J N Galgiani
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

2.  Neuropathology of heart transplantation: 23 cases.

Authors:  C G Montero; A J Martinez
Journal:  Neurology       Date:  1986-09       Impact factor: 9.910

3.  Disseminated aspergillosis complicating orthotopic liver transplantation for fulminant hepatic failure refractory to corticosteroid therapy.

Authors:  J J Brems; J R Hiatt; A S Klein; J Hart; G el-Khoury; D Winston; J M Millis; R W Busuttil
Journal:  Transplantation       Date:  1988-09       Impact factor: 4.939

4.  Initial experience in therapy for progressive mycoses with itraconazole, the first clinically studied triazole.

Authors:  A Ganer; E Arathoon; D A Stevens
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

5.  Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results.

Authors:  B Dupont; E Drouhet
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

Review 6.  Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models.

Authors:  J Van Cutsem; F Van Gerven; P A Janssen
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

7.  [Aspergillosis following liver transplantation as a hospital infection].

Authors:  T S Lie; M Höfer; C Höhnke; L Krizek; E Kühnen; A Iwantscheff; O Köster; A Overlack; J Vogel; K Rommelsheim
Journal:  Dtsch Med Wochenschr       Date:  1987-02-20       Impact factor: 0.628

8.  Itraconazole: pharmacologic studies in animals and humans.

Authors:  H Van Cauteren; J Heykants; R De Coster; G Cauwenbergh
Journal:  Rev Infect Dis       Date:  1987 Jan-Feb

9.  Infections after liver transplantation. An analysis of 101 consecutive cases.

Authors:  S Kusne; J S Dummer; N Singh; S Iwatsuki; L Makowka; C Esquivel; A G Tzakis; T E Starzl; M Ho
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889

10.  Infections in pediatric orthotopic heart transplant recipients.

Authors:  M Green; E R Wald; F J Fricker; B P Griffith; A Trento
Journal:  Pediatr Infect Dis J       Date:  1989-02       Impact factor: 2.129

View more
  7 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

2.  Multiple intracranial fungal abscesses in an immunocompetent infant treated surgically.

Authors:  Ashutosh Khandelwal; Noufal Basheer; Ashok K Mahapatra
Journal:  J Pediatr Neurosci       Date:  2014-05

3.  Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression.

Authors:  R Selby; C B Ramirez; R Singh; I Kleopoulos; S Kusne; T E Starzl; J Fung
Journal:  Arch Surg       Date:  1997-03

4.  Orthotopic liver transplantation for urea cycle enzyme deficiency.

Authors:  S Todo; T E Starzl; A Tzakis; K J Benkov; F Kalousek; T Saheki; K Tanikawa; W A Fenton
Journal:  Hepatology       Date:  1992-03       Impact factor: 17.425

5.  CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  M Schmidt-Hieber; G Silling; E Schalk; W Heinz; J Panse; O Penack; M Christopeit; D Buchheidt; U Meyding-Lamadé; S Hähnel; H H Wolf; M Ruhnke; S Schwartz; G Maschmeyer
Journal:  Ann Oncol       Date:  2016-04-06       Impact factor: 32.976

6.  Invasive aspergillosis in a patient with end stage renal disease.

Authors:  Neslihan Cicek; Nurdan Yildiz; Eda Kepenekli Kadayifci; Ibrahim Gokce; Harika Alpay
Journal:  Med Mycol Case Rep       Date:  2017-07-11

Review 7.  Lethal thrombosis of the iliac artery caused by Aspergillus fumigatus after liver transplantation: case report and review of the literature.

Authors:  Jan-Paul Gundlach; Rainer Günther; Helmut Fickenscher; Marcus Both; Christoph Röcken; Thomas Becker; Felix Braun
Journal:  BMC Surg       Date:  2019-12-27       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.